No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HEAR240517P17000
- 1.20
- +0.25+26.32%
15min DelayTrading May 13 11:29 ET
1.20High0.93Low
0.93Open0.95Pre Close600 Volume613 Open Interest17.00Strike Price65.05KTurnover52.56%IV-0.34%PremiumMay 17, 2024Expiry Date1.15Intrinsic Value100Multiplier4DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type-0.8706Delta0.2360Gamma13.21Leverage Ratio-0.0196Theta-0.0014Rho-11.50Eff Leverage0.0037Vega
Intraday
- 5D
- 1D
News
Is Turtle Beach (HEAR) Stock Outpacing Its Computer and Technology Peers This Year?
Turtle Beach: A Strong Buy on Robust Q1 Performance and Strategic Acquisitions
Turtle Beach Price Target Maintained With a $19.00/Share by Wedbush
Turtle Beach Price Target Maintained With a $19.00/Share by Wedbush
Wedbush Remains a Buy on Turtle Beach (HEAR)
Q1 2024 Turtle Beach Corp Earnings Call
Turtle Beach Corp (HEAR) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and ...
Comments
Turtle Beach is expected to outpace the industry with a forecasted 46% annual growth until 2024, indicating improving business conditions.
Analysts Just Published A Bright New Outlook For Turtle Beach Corporation's (NASDAQ:HEAR) 2
$Turtle Beach(HEAR.US$
like turtle..😅
like turtle..😅
$Turtle Beach(HEAR.US$ tipsy📈
1
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
21
Gainers:
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
17
7
Read more